Yoshikazu Fujimori

发表

Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects.

O. Nakanishi, T. Ikeda, Junichi Kobayashi, 2020, Bioorganic & medicinal chemistry.

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

Yoshikazu Fujimori, F. Itoh, H. Fujikura, 2007, Journal of Pharmacology and Experimental Therapeutics.

Pulmonary , gastrointestinal and urogenital pharmacology Mizagli fl ozin , a novel selective SGLT 1 inhibitor , exhibits potential in the amelioration of chronic constipation

T. Onozato, Yoshikazu Fujimori, H. Takeda, 2017 .

Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor.

Toshihiro Nishimura, Hidemasa Hikawa, I. Azumaya, 2021, Bioorganic & medicinal chemistry.

Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models

Yoshikazu Fujimori, H. Fujikura, Yukiko Ishikawa-Takemura, 2008, Journal of Pharmacology and Experimental Therapeutics.

KPR-2579, a novel TRPM8 antagonist, inhibits acetic-acid-induced bladder hyperactivity via mechanosensitive afferent C-fibers in rats

Y. Homma, O. Nakanishi, Y. Igawa, 2017 .

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.

Yoshikazu Fujimori, Yukiko Ishikawa-Takemura, M. Isaji, 2009, European journal of pharmacology.

Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists.

Tomonaga Ozawa, O. Nakanishi, T. Ikeda, 2017, Bioorganic & medicinal chemistry.

KPR-5714, a Novel Transient Receptor Potential Melastatin 8 Antagonist, Improves Overactive Bladder via Inhibition of Bladder Afferent Hyperactivity in Rats

O. Nakanishi, Y. Igawa, Hideaki Hirasawa, 2020, The Journal of Pharmacology and Experimental Therapeutics.

KPR‐2579, a novel TRPM8 antagonist, inhibits acetic acid‐induced bladder afferent hyperactivity in rats

H. Kume, Y. Homma, O. Nakanishi, 2018, Neurourology and urodynamics.

Longitudinal analysis of motor symptoms and histopathology in woozy mice, a model of cerebellar ataxia

T. Onozato, Yoshikazu Fujimori, H. Takeda, 2017, Neuroreport.

Efficacy of the combination of KPR-5714, a novel transient receptor potential melastatin 8 (TRPM8) antagonist, and β3-adrenoceptor agonist or anticholinergic agent on bladder dysfunction in rats with bladder overactivity.

T. Fujita, O. Nakanishi, Yoshikazu Fujimori, 2021, European journal of pharmacology.

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.

Yoshikazu Fujimori, H. Kusama, K. Ojima, 2009, European journal of pharmacology.